Sage Therapeutics
(NASDAQ:SAGE)
$13.48
0.91[7.24%]
Last update: 12:12PM Get Real Time Here
Q1 2024 Earnings in 7 days from now on Thu Apr 25th, before the market open
Conference call scheduled in 7 days at 8:00 AM Click to view the webcast
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Sage Therapeutics Stock (NASDAQ:SAGE), Quotes and News Summary

Sage Therapeutics Stock (NASDAQ: SAGE) stock price, news, charts, stock research, profile.

Open$12.240
Close-
Volume / Avg.614.520K / 971.535K
Day Range12.200 - 13.500
52 Wk Range10.920 - 59.990
Market Cap$810.238M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
24
Short Interest
21.59%
Days to Cover11.01

Recent News

Crude Oil Dips 3%; U.S. Bancorp Profit Tops Views
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling more than 100 points on Wednesday. The Dow traded up 0.04% to 37,813.77 while the NASDAQ fell 0.78% to 15,742.21. The S&P 500 also fell, dropping, 0.34% to 5,034.17.
Avi Kapoor
Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of The Travelers Companies, Inc. (NYSE: TRV) fell sharply during Wednesday’s session following first-quarter earnings.
Avi Kapoor
Nasdaq Down Over 1%; Sage Therapeutics Shares Plunge
U.S. stocks traded lower midway through trading, with the Dow Jones index falling around 100 points on Wednesday. The Dow traded down 0.32% to 37,678.27 while the NASDAQ fell 1.16% to 15,681.95. The S&P 500 also fell, dropping, 0.74% to 5,013.98.
Avi Kapoor
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Nov 23
0
0
0
0
Dec 23
2
Feb
1
Mar
1
2
1
Apr
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
2.0
Sell
Strong Buy
Buy
Hold
Sell
Strong Sell
About Sage Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicine...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
SAGE
SPRY

FAQ

Q

How do I buy Sage Therapeutics (SAGE) stock?

A

You can purchase shares of Sage Therapeutics (NASDAQ: SAGE) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Sage Therapeutics's (SAGE) competitors?

A

Other companies in Sage Therapeutics’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), Cabaletta Bio (NASDAQ:CABA), 89bio (NASDAQ:ETNB), Cogent Biosciences (NASDAQ:COGT) and Pharming (NASDAQ:PHAR).

Q

What is the target price for Sage Therapeutics (SAGE) stock?

A

The latest price target for Sage Therapeutics (NASDAQ: SAGE) was reported by Scotiabank on Thursday, April 18, 2024. The analyst firm set a price target for 19.00 expecting SAGE to rise to within 12 months (a possible 40.95% upside). 48 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Sage Therapeutics (SAGE)?

A

The stock price for Sage Therapeutics (NASDAQ: SAGE) is $13.48 last updated Today at April 18, 2024 at 12:12 PM EDT.

Q

Does Sage Therapeutics (SAGE) pay a dividend?

A

There are no upcoming dividends for Sage Therapeutics.

Q

When is Sage Therapeutics (NASDAQ:SAGE) reporting earnings?

A

Sage Therapeutics’s Q1 earnings are confirmed for Thursday, April 25, 2024.

Q

Is Sage Therapeutics (SAGE) going to split?

A

There is no upcoming split for Sage Therapeutics.

Q

What sector and industry does Sage Therapeutics (SAGE) operate in?

A

Sage Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch